Cancer

Vaping: A valuable harm reduction tool or a public health concern? Experts weigh in

What is Canada to do about e-cigarettes? Does vaping pose a legitimate public health threat or is it a far safer alternative for those who would otherwise be vulnerable to the known harms of cigarettes?

We must address the dangers of e-cigarettes and dual use

It's time to move beyond oversimplified narratives and confront the complex realities of e-cigarette use.

Why screening guideline committees should not include ‘experts’ as voting members

The challenge to those who do not like the Canadian Task Force recommendations is this: Can you provide or research the new evidence required to show how a different policy is better?

Who you are and where you live shouldn’t determine your ability to survive cancer

Let us commit to a future in which all people have the resources and support to prevent and treat cancer so that no one is left behind.

Financial side-effects of treatment can be devastating in our ‘free’ health-care system

Health-care providers must also begin to take proactive steps to ensure that patients are not only aware of the medical side effects of their care and treatments, but the financial side effects, too.

Financial toxicity: The relationship between cancer and poverty

Beating cancer doesn't always mean patients will lead healthy and fulfilling lives. They also face the challenge of staying out of the poverty cycle and debt traps throughout the course of their treatment.

Prostate-cancer screening: Guideline reflects lack of knowledgeable expert input

The last guideline on prostate-cancer screening was published in 2014. At the time, the task force approached the Canadian Urologic Association (CUA) and asked that it provide an expert panel of “stakeholders” to provide input....We found that the task force guideline utilized only data from a small number of randomized trials and ignored scores of other relevant studies. The analysis of the studies that were reviewed was superficial and the guideline was flawed.

Breast-cancer screening: Balancing harm vs. risks

One would expect that the priority of the Canadian Task Force on Preventive Health Care on breast-cancer screening would be to recommend practices that would maximally reduce mortality and morbidity from disease. In the case of breast cancer, this suggests focusing on effective guidelines for those who are at increased probability of developing disease or increased risk of late diagnosis and the consequent higher likelihood of premature death or morbidity associated with treating advanced disease.

Excluding experts doesn’t make sense

Most assume that the Canadian task force guidelines are led by content expert specialist clinicians. But this is not the case. The task force says it excludes content experts from genuine involvement in guideline development to avoid conflicts of interest. However, in the Canadian health-care context, this is not a valid argument.

Do doctors know enough about the commercial determinants of health?

Private sector activities have a real impact on people's health. We need to promote healthy cross-industry regulation and scrutinize the role that private interests play in the health-policy arena to help safeguard the health of patients.

It’s not all pretty in pink: To prevent breast cancer, let’s stop missing the forest for the trees

Breast cancer rates, even among young people, are on the rise. For this Breast Cancer Awareness month, there's more we could be doing to prevent the disease before it starts.

Mushrooms, nuts and collard greens: Nutrition and how to lower the odds of breast cancer

Breast cancer is the product of many factors over a lifetime. While some of those factors are out of our control, others like diet offer opportunities to mitigate risk.

Should “magic mushrooms” be legalized? Experts weigh in

Psilocybin, a psychedelic compound found in "magic mushrooms", is making waves for its therapeutic benefits in treating psychiatric conditions like major depressive disorder and end-of-life anxiety. But does that mean it should be legalized? We asked a panel of experts to weigh in.

Lung-cancer screening – primum non nocere (first, do no harm)!

Lung cancer is the number one global killer among cancers. Early detection can help patients' chance of survival but current screening measures also come with mixed benefits and risks.

We have the tools to prevent ovarian cancer. Why aren’t we using them?

About 20 per cent of the ovarian cancer cases in Canada diagnosed each year are in people who carry a mutation and are most likely preventable. Genetic testing can become more accessible. Why are we waiting? 

Sometimes the truth is unbearable

The health-care system is failing Canadians with lethal consequences. Policymakers need to make urgent changes now to address delays in access to care.

Trust us to make our own decisions about breast-cancer screenings

The new U.S. guidance on breast-cancer screening shouldn’t be controversial or a “both sides” issue in Canada. It should serve as a model for the change we need.

Cancer survival rates have significantly improved. Now we must pay attention to rehabilitation

Cancer survivors should not be left to feel like they need to manage their impairments on their own. There are models for cancer centres across Canada that can provide timely and comprehensive rehabilitation services.

Synthetic data may revolutionize clinical trials – and save lives

Behind each clinical trial, there are real human lives at stake. Advancements in synthetic data could lead us to a future in which every cancer patient enrolled in a clinical trial is guaranteed hope.

Having breast cancer impacts sexuality: Why don’t we talk about it?

It's common for women to struggle with sexual health issues after breast cancer. But it isn’t just our bodies that change; the experience of cancer changes our relationship with time, aging and even the arc of life that we imagine for ourselves.